Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Aug 2025 – 20 Aug 2026, limited by Bandhan Multi-Factor Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bandhan Multi-Factor Fund | Nifty 500 |
|---|---|---|
| 01 Aug 2025 | ₹100.00 | ₹100.00 |
| 02 Sep 2025 | ₹99.08 | ₹100.22 |
| 04 Oct 2025 | ₹100.22 | ₹101.56 |
| 05 Nov 2025 | ₹101.54 | ₹104.42 |
| 07 Dec 2025 | ₹103.67 | ₹105.12 |
| 08 Jan 2026 | ₹107.05 | ₹104.44 |
| 09 Feb 2026 | ₹108.69 | ₹104.45 |
| 13 Mar 2026 | ₹98.59 | ₹94.34 |
| 14 Apr 2026 | ₹100.91 | ₹97.82 |
| 16 May 2026 | ₹99.84 | ₹99.37 |
| 17 Jun 2026 | ₹99.94 | ₹101.92 |
| 19 Jul 2026 | ₹100.23 | ₹102.92 |
| 20 Aug 2026 | ₹100.32 | ₹103.70 |
| Metric | Bandhan · Regular NAV ₹9.88 Very High risk ★★☆☆☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| -0.89% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +0.31% | +12.26% | |
| -3.47% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 13.13% | 15.62% | |
| -0.56 | 0.43 | |
| -0.73 | 0.59 | |
| -12.85% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 3.88% | 2.39% | |
| ₹671.87Cr | ₹1,161Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| — | 45% | |
| Brijesh Shah | — | |
| 01 Aug 2025 | — | |
| 34 | — | |
| 39.4% | — | |
| 2.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.